ts emisphere biosciences logo

Investor Relations

Corporate Profile    Stock Quote
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Emisphere Technologies, Inc.'s financial performance into perspective.  
EMIS (Common)
Exchange BB
Price $0.56
Change (%) +0.04 (up7.60%)
Volume 200
Data as of Oct 6, 2015 9:35 AM ET
Minimum 20 minute delay
Refresh quote
Recent Releases
Sep 2, 2015
Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference

Aug 26, 2015
Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1

Aug 12, 2015
Emisphere Reports Second Quarter 2015 Financial Results

Copyright © Emisphere, All rights reserved